Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay

Biologicals

Volumn 33, Issue 2, 2005, Pages 71-79

  Schalk, J A C ^a   De Vries, C G J C A ^a   Jongen, P M J M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE; TRIPLE VACCINE;

ARTICLE; CELL CULTURE; CYTOPATHOGENIC EFFECT; DRUG POTENCY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SEROLOGY; VALIDATION PROCESS; VIRUS CULTURE;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; DNA PRIMERS; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VIRUS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; RUBELLA VIRUS; VERO CELLS; VIRULENCE; VIRUS REPLICATION;

MEASLES VIRUS; MUMPS VIRUS; RUBELLA VIRUS;

EID: 20444380988     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biologicals.2005.01.001     Document Type: Article

References (14)

1. J.A.C. Schalk, C. van den Elzen, H. Ovelgönne, C. Baas, and P.M.J.M. Jongen Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR J Virol Methods 117 2004 179 187
2. A. Fukuda, F. Şengün, H.E. Sarpay, T. Konobe, S. Saito, and Y. Umino Parameters for plaque formation in potency assay of Japanese measles vaccines J Virol Methods 61 1996 1 6
3. Y. Umino Improved potency assay of rubella vaccine: parameters for plaque formation J Virol Methods 51 1995 317 328
4. R.S. Van Binnendijk, S. van den Hof, H. van den Kerkhof, R.H.G. Kohl, F. Woonink, and G.A.M. Berbers Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands J Infect Dis 188 2003 898 903
5. S. Kreis, E. Vardas, and T. Whistler Sequence analysis of the nucleocapsid gene of measles virus isolates from South Africa identifies a new genotype J Gen Virol 78 1997 1581 1587
6. T.J. Bosma, K.M. Corbett, S. O'Shea, J.E. Banatvala, and J.M. Best PCR for detection of rubella virus RNA in clinical samples J Clin Microbiol 33 1995 1075 1079
7. European pharmacopoeia 4th ed. 2002 Directorate for the quality of medicines of the council of Europe (EDQM) Strasbourg, France
8. C. Ramakers, J.M. Ruijter, R.H. Lekanne Deprez, and A.F.M. Moorman Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data Neurosci Lett 339 2003 62 66
9. M.A. Afzal, A.R. Pickford, T. Forsey, and P.D. Minor Heterogeneous mumps vaccine Lancet 340 1992 980 981
10. M.A. Afzal, A.R. Pickford, T. Forsey, A.B. Heath, and P.D. Minor The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates J Gen Virol 74 1993 917 920
11. Y. Umino, S. Saito, A. Fukuda, M. Hishiyama, and A. Sugiura Improvement in potency assay of measles-mumps-rubella trivalent vaccine: interference between components and measures for its elimination J Virol Methods 27 1990 159 168
12. J. Desmyter, J.L. Melnick, and W.E. Rawls Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells J Virol 2 1986 955 961
13. T. Forsey, A.B. Heath, and P.D. Minor A collaborative study to assess the proficiency of laboratory estimates of potency of live measles vaccines Biologicals 20 1992 233 234
14. T. Forsey, A.B. Heath, and P.D. Minor A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccines Biologicals 21 1993 239 249